Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
The effect of COVID certificates on vaccine uptake, health outcomes, and the economy
2022 StandoutNobel
Ambient temperature and subsequent COVID-19 mortality in the OECD countries and individual United States
2021
Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination
2004
Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: A pilot study
2005
Review article: hepatitis B and liver transplantation
2006
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Treating hepatitis C infection in liver transplant recipients
2006
Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation
2005
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
2007
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
2007
New Era of Liver Transplantation for Hepatitis B
2002
Impact of Donor Age and Year of Transplantation on Graft and Patient Survival Following Liver Transplantation for Hepatitis C Virus
2006
Long-Term Follow-Up of Portopulmonary Hypertension
2007
Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients
2016
Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment
2006
Management of hepatitis B: 2000—Summary of a workshop
2001
The Impact of IL28B Genetic Variants on Recurrent Hepatitis C in Liver Transplantation: Significant Lessons from a Dual Graft Case
2011
Successful Liver Transplantation Following Medical Management of Portopulmonary Hypertension: A Single-Center Series
2006
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
2006
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension
2004
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Epstein–Barr virus load monitoring: its role in the prevention and management of post‐transplant lymphoproliferative disease
2001
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
2004
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression
2006
24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience
2010
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
The natural history of recurrent hepatitis C and what influences this
2008
Mild to moderate pulmonary hypertension in liver transplantation
2013
International Liver Transplant Society Practice Guidelines
2016
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
2004 Standout
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Global burden of liver disease: 2023 update
2023 Standout
Pulmonary–Hepatic vascular Disorders (PHD)
2004
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation
2004
Portopulmonary Hypertension
2014
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
2012 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results
2003
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis B
2007
Graft histology characteristics in long-term survivors of pediatric liver transplantation
2008
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
2006
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Pulmonary Arterial Hypertension in France
2006 Standout
Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database
2004
Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years
2017
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Multi-State Models for Panel Data: ThemsmPackage forR
2011 Standout
Human Cytomegalovirus Inhibits Cytokine-Induced Macrophage Differentiation
2004
Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective
2005
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of David Mutimer being referenced
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
2002
Outcome of liver transplantation for patients with pulmonary hypertension
2002
Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group
2019
LAMIVUDINE WITHOUT HBIg FOR PREVENTION OF GRAFT REINFECTION BY HEPATITIS B: LONG-TERM FOLLOW-UP
2000
QUANTITATION OF EPSTEIN-BARR VIRUS DNA IN THE BLOOD OF ADULT LIVER TRANSPLANT RECIPIENTS1
2000
Hepatitis C Virus and Nonliver Solid Organ Transplantation
2012
ENHANCED (CYTOMEGALOVIRUS) VIRAL REPLICATION ASSOCIATED WITH SEPTIC BACTERIAL COMPLICATIONS IN LIVER TRANSPLANT RECIPIENTS
1997
Modeling Costs and Cost-Effectiveness of Different CMV Management Strategies in Liver Transplant Recipients as a Support for Current and Future Decision Making
2002